Survanta 4ml

Suspension

Pack Size : 1 bottle x 1 packet

Generics : Phospholipids

Manufacturer : Unimed & Unihealth Manufacturers Ltd.

Best Price * TK 27,500.00

* Delivery will be done in Dhaka city only.

Alternative Product

More Information About - Survanta 4ml

Description

Generic Name

Phospholipids

Precaution

Infants <600 g birth wt. For intratracheal use only.

Indication

Resp distress syndrome (RDS) in premature infants.

Contra Indication

None known.

Dose

N/A

Side Effect

Transient bradycardia. O2 desaturation, endotracheal tube reflux & blockage, pallor, vasoconstriction, hypotension, HTN, hypocarbia, hypercarbia & apnea.

Pregnancy Category

Name : Not Classified

Description

FDA has not yet classified the drug into a specified pregnancy category.

Mode of Action

Natural bovine pulmonary surfactant; replaces deficient endogenous lung surfactant in neonates with respiratory distress syndrome. Surfactant prevents the alveoli from collapsing during expiration by lowering surface tension between alveolar surfaces and air.

Interaction

N/A

Pregnancy Category Note

N/A

Adult Dose

N/A

Child Dose

Prevention in premature infant <1250 g birthwt or w/ evidence of surfactant deficiency Preferably w/in 15 mins of birth. Rescue Preferably by 8 hr of age. 4 mL/kg birth wt(100 mg of phospholipids/kg birth wt) intratracheally up to 4 doses in 1st 48 hr. Doses should not be given more frequently than 6 hrly. To be administered as soon as possible.

Renal Dose

N/A

Administration

N/A

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.